1 – 24 of 24
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
2024) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
(
- Contribution to journal › Article
- 2023
-
Mark
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
(
- Contribution to journal › Article
-
Mark
The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer’s disease : a natural language processing study
(
- Contribution to journal › Article
-
Mark
Effects of the DICE Method to Improve Timely Recognition and Treatment of Neuropsychiatric Symptoms in Early Alzheimer's Disease at the Memory Clinic : The BEAT-IT Study
(
- Contribution to journal › Article
-
Mark
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia
(
- Contribution to journal › Article
- 2022
-
Mark
Evaluating the DICE method to improve early recognition and treatment of neuropsychiatric symptoms in early Alzheimer’s disease
(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
A Modified Progressive Supranuclear Palsy Rating Scale
(
- Contribution to journal › Article
-
Mark
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Genotype–Phenotype Relations for the Atypical Parkinsonism Genes : MDSGene Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
A multicentre validation study of the diagnostic value of plasma neurofilament light
(
- Contribution to journal › Article
- 2020
-
Mark
Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies
(
- Contribution to journal › Article
-
Mark
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
(
- Contribution to journal › Article
-
Mark
Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders
(
- Contribution to journal › Article
- 2019
-
Mark
CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
(
- Contribution to journal › Article
-
Mark
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease : Protocol of the BEAT-IT study
(
- Contribution to journal › Article
-
Mark
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
(
- Contribution to journal › Article
- 2018
-
Mark
Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease : A Case Report
(
- Contribution to journal › Article
-
Mark
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies : a genome-wide linkage and sequencing study
(
- Contribution to journal › Article
- 2017
-
Mark
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
(
- Contribution to journal › Scientific review
-
Mark
Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
(
- Contribution to journal › Article
- 2016
-
Mark
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
(
- Contribution to journal › Article
- 2014
-
Mark
Frontotemporal dementia and its subtypes: a genome-wide association study.
(
- Contribution to journal › Article
- 2012
-
Mark
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
(
- Contribution to journal › Article